Clinical Trial

Remimazolam on the Incidence of Postoperative Acute Kidney Injury

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
We hypothesized that in patients undergoing elective hepatobiliary-pancreatic surgery, the group in which anesthesia is induced and maintained with remimazolam during surgery would maintain hemodynamic stability and reduce the incidence of postoperative acute kidney injury compared to propofol. The purpose is to provide practical evidence for perioperative management differentiated from other surgeries for hepatobiliary-pancreatic surgery patients for whom intraoperative fluid therapy is restricted.
Trial Details
NCT Number NCT07674719
Lead Sponsor Seoul National University Bundang Hospital
Conditions Remimazolam, Propofol, Acute Kidney Injury, Hemodynamic Stability, Hepatobiliary Surgery, Fluid Therapy, Fluid Therapy DURING SURGERY
Enrollment 78 participants
Start Date 2026-06-26
Primary Completion 2027-06-26 (estimated)
Study Completion 2028-06-26 (estimated)
Updated on ClinicalTrials.gov 2026-06-29